Mater

START Center for Cancer Care to Open New Locations in Lisbon and Dublin

Retrieved on: 
Tuesday, November 15, 2022
University, Education, Health, Pharmaceutical, Oncology, Training, Research, Hospitals, Science, Clinical Trials, Continuing, FDA, Mater Misericordiae University Hospital, Mater, CHLN, Hospital de São José, Cancer, Research, Instituto de Medicina Molecular, START, Mater Hospital Pimlico, Hospital de Santa Maria, Sister, Union, Faculdade de Medicina da Universidade Federal de Minas Gerais, University College Dublin, The Sisters of Mercy, Hospital, Patient, Pharmaceutical industry, Medicine

The START Center for Cancer Care , a San Antonio-based oncology early-phase clinical research site network, will open Portugals first facility in Lisbon in late 2022 and is slated to open Irelands first early-phase clinical research facility in Dublin in early 2023.

Key Points: 
  • The START Center for Cancer Care , a San Antonio-based oncology early-phase clinical research site network, will open Portugals first facility in Lisbon in late 2022 and is slated to open Irelands first early-phase clinical research facility in Dublin in early 2023.
  • For Lisbon, the principal investigator had previously trained at the START training program in START Madrid.
  • START Center operates six existing locations across the U.S. and Spain, which makes it one of the largest early-phase clinical research sites in the world.
  • The dedication to finding and developing the best cancer treatments drives each of us, START Center President and Founder Lon S. Smith, M.D.

Informatica Helps Australia’s Mater Drive Cloud Modernization with Trusted Data for Better Healthcare Service

Retrieved on: 
Tuesday, November 8, 2022
Data Management, Health, Technology, Software, General Health, Networks, Internet, Cloud, Diagnosis, Software, Patient, Mater, Cloud Data Management Interface, NYSE, Digital, Decision-making, Data management, INFA, Student, Education, Health, Unified communications as a service, IDMC, Emergency, Efficiency, AI, Research, Network equipment, Medical imaging, Informatica

Informatica (NYSE: INFA), an enterprise cloud data management leader, today announced it is partnering with one of the largest not-for-profit healthcare providers in Australia, Mater, to help the organization modernize and accelerate data migration to the cloud to fuel trusted data for decision making and predictive analytics.

Key Points: 
  • Informatica (NYSE: INFA), an enterprise cloud data management leader, today announced it is partnering with one of the largest not-for-profit healthcare providers in Australia, Mater, to help the organization modernize and accelerate data migration to the cloud to fuel trusted data for decision making and predictive analytics.
  • In fact, trusted data is even more critical now as demonstrated during recent emergencies and in response to crises like Covid.
  • Mater is leveraging cloud capabilities to modernize our data management and data governance capabilities which are fundamental to being a healthcare, health research and education provider in the digital age.
  • Informatica (NYSE:INFA), an Enterprise Cloud Data Management leader, empowers businesses to realize the transformative power of data.

MEDITECH Expanse Selected by Mater Private, Ireland's Leader in Cancer and Cardiac Care

Retrieved on: 
Tuesday, March 29, 2022
Technology, Hospitals, Cardiology, Software, Practice Management, Managed Care, Pharmaceutical, Health, Data Management, Oncology, Approximation error, LinkedIn, COO, United Kingdom, Growth, Nursing, Software suite, Electronic health record, MEDITECH, Hospital, Woman, Cancer, Private network, Health, Software, Sepsis, Technology, Twitter, Mater, EHR, Oncology, Physician, Patient safety, KLAS, Trust law, Conditional sentence, Efficiency, Patient, Cardiology, Expanse, Facebook

Mater Private Network (Dublin, Ireland) has selected MEDITECH Expanse to provide a connected Electronic Health Record (EHR) throughout its hospitals, departments, and care settings.

Key Points: 
  • Mater Private Network (Dublin, Ireland) has selected MEDITECH Expanse to provide a connected Electronic Health Record (EHR) throughout its hospitals, departments, and care settings.
  • The organisation is recognized as a national leader in cancer and cardiac care.
  • Mater Private Network plans to leverage Expanse as part of their focus on patient-centred care.
  • Mater Private Network is a leader in leveraging technology and innovation to provide exceptional care in Ireland, said Helen Waters, MEDITECH Executive Vice President and COO.

Microba Life Sciences Becomes First Australian Microbiome Company Granted ISO15189 Accreditation by NATA

Retrieved on: 
Thursday, December 16, 2021
Health, Medical Devices, Infectious Diseases, Hospitals, Other Health, General Health, Biotechnology, Hospital, NGS, Growth, Partner, Royal college, Translational Research Institute, RCPA, Accreditation, NATA, Translational Research Institute (Australia), National Association of Testing Authorities, National Association, Infection, Marie Cassidy, Associate, Partnership, Health, Mater, Medicine, Pharmaceutical industry, Medical device, Antibiotics

Microba has applied its world-leading technology for microbiome analysis to unlock diagnostic applications, receiving ISO15189 accreditation for a new untargeted NGS based assay of stool samples.

Key Points: 
  • Microba has applied its world-leading technology for microbiome analysis to unlock diagnostic applications, receiving ISO15189 accreditation for a new untargeted NGS based assay of stool samples.
  • Microba Life Sciences is a precision microbiome science company with a mission of improving human health.
  • With world-leading technology for microbiome analysis, Microba is developing novel treatments and innovative testing solutions that harness the microbiome for better health outcomes.
  • Microba partners with leading organisations globally to drive microbiome discoveries and advance new applications for the role of the microbiome in human health.